logo-loader
viewPolar Capital Global Healthcare Trust PLC

Polar Capital Global Healthcare Trust upbeat on the outlook for the sector

Fund managers James Douglas and Gareth Powell reckon valuations for the drug and device makers and care providers “remain attractive” while the industry has “strong fundamentals, news flow and corporate activity”

Polar Capital Global Healthcare Trust PLC -

After a strong end to the year, there may be a degree of circumspection moving into 2020, according to the managers of Polar Capital Global Healthcare Trust PLC (LON:PCGH).

“The markets feel extended in the very short term, with sentiment having improved significantly, so do not be surprised if we see a near-term pullback,” said James Douglas and Gareth Powell in a note to investors.

WATCH: Polar Capital upbeat on the outlook for the healthcare sector

However, they reckon valuations for the drug and device makers and care providers “remain attractive” while the industry has “strong fundamentals, news flow and corporate activity”.

Outperformance 

This, the Polar Capital pair said, should “should create a recipe for outperformance in 2020”.

However, they recognised that some investors are “climbing a wall of worry” over the potential re-election of Donald Trump later this year, whose piecemeal destruction of the Affordable Care Act (Obamacare) is seen as emblematic of his stance of matters health.

However, Douglas and Powell said it might be worth reflecting on the performance of the US semiconductors industry during the US-China trade stand-off (graphic below).

Rather than crumble as America went on the offensive, the component companies of the semiconductors index gained a weighted average 62% last year.

“With the presidential election being healthcare’s trade war, anything close to the performance of semiconductor stocks in 2019 would be a great outcome,” the Polar managers said.

Trust performed well

The Polar Capital Healthcare Trust itself finished 2019 strongly, gaining 1.64%. That was well ahead of its benchmark, the Morgan Stanley Global Healthcare Index, which was up 1.06% in December.

Positive contributors to performance during December were Horizon Pharma, Eli Lilly and Varian Medical Systems, said Polar, with Lilly benefiting from “upbeat” 2020 financial guidance.

The company’s top holdings are Merck, Abbvie and Intuitive Surgical. Its biggest exposure is to the healthcare equipment sub-sector.

Quick facts: Polar Capital Global Healthcare Trust PLC

Price: 194.5 GBX

LSE:PCGH
Market: LSE
Market Cap: £235.87 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Polar Capital Global Healthcare Trust PLC named herein, including the promotion by the Company of Polar Capital Global Healthcare Trust PLC in...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Polar Capital upbeat on the outlook for the healthcare sector

According to James Douglas, fund manager of Polar Capital Global Healthcare Trust PLC (LON:PCGH), the US election isn’t affecting market sentiment in his sector quite as much as it has. Douglas, together with his team reckon valuations for the drug and device makers and care...

on 23/1/20

2 min read